$ATHA Athira Pharma, Inc. Insider Trading Week 38/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Athira Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Athira Pharma, Inc. in week 38/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 1,644,785 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 17.00 | 1,058,824 | 18,000,008 | 3,114,805 | 2.1 M to 3.1 M (+51.50 %) |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 1,644,785 | 0 | 2,055,981 | 411.2 K to 2.1 M (+400.00 %) |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | EDELMAN JOSEPH | Director | Option Exercise | C | 0.00 | 1,644,785 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | EDELMAN JOSEPH | Director | Buy | P | 17.00 | 1,058,824 | 18,000,008 | 3,114,805 | 2.1 M to 3.1 M (+51.50 %) |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | EDELMAN JOSEPH | Director | Buy | C | 0.00 | 1,644,785 | 0 | 2,055,981 | 411.2 K to 2.1 M (+400.00 %) |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | FLUKE JOHN M JR | Director | Option Exercise | C | 0.00 | 6,731 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | FLUKE JOHN M JR | Director | Option Exercise | C | 0.00 | 51,831 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | FLUKE JOHN M JR | Director | Option Exercise | C | 0.00 | 12,610 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | FLUKE JOHN M JR | Director | Buy | C | 0.00 | 6,731 | 0 | 6,731 | 0 to 6.7 K |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | FLUKE JOHN M JR | Director | Buy | C | 0.00 | 51,831 | 0 | 114,881 | 63.1 K to 114.9 K (+82.21 %) |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | FLUKE JOHN M JR | Director | Buy | C | 0.00 | 12,610 | 0 | 63,050 | 50.4 K to 63.1 K (+25.00 %) |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Option Exercise | C | 0.00 | 6,563 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Option Exercise | C | 0.00 | 6,563 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Option Exercise | C | 0.00 | 6,563 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Option Exercise | C | 0.00 | 13,126 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Buy | C | 0.00 | 6,563 | 0 | 6,563 | 0 to 6.6 K |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Buy | C | 0.00 | 6,563 | 0 | 6,563 | 0 to 6.6 K |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Buy | C | 0.00 | 6,563 | 0 | 6,563 | 0 to 6.6 K |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Buy | C | 0.00 | 13,126 | 0 | 63,566 | 50.4 K to 63.6 K (+26.02 %) |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | RTW INVESTMENTS, LP | 10% Owner | Option Exercise | C | 0.00 | 1,535,131 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | RTW INVESTMENTS, LP | 10% Owner | Buy | P | 17.00 | 750,000 | 12,750,000 | 2,668,913 | 1.9 M to 2.7 M (+39.08 %) |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | RTW INVESTMENTS, LP | 10% Owner | Buy | C | 0.00 | 1,535,131 | 0 | 1,918,913 | 383.8 K to 1.9 M (+400.00 %) |